Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Bon Natural Life Ltd (BON)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/18/2025: BON (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -10.09% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/18/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.94M USD | Price to earnings Ratio 0.32 | 1Y Target Price 77.5 |
Price to earnings Ratio 0.32 | 1Y Target Price 77.5 | ||
Volume (30-day avg) 5564831 | Beta -0.47 | 52 Weeks Range 1.14 - 62.00 | Updated Date 06/19/2025 |
52 Weeks Range 1.14 - 62.00 | Updated Date 06/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.25 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.67% | Operating Margin (TTM) 7.86% |
Management Effectiveness
Return on Assets (TTM) 2.16% | Return on Equity (TTM) 0.91% |
Valuation
Trailing PE 0.32 | Forward PE 2.35 | Enterprise Value 13621140 | Price to Sales(TTM) 0.36 |
Enterprise Value 13621140 | Price to Sales(TTM) 0.36 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA 5.58 | Shares Outstanding 3675680 | Shares Floating 1695165 |
Shares Outstanding 3675680 | Shares Floating 1695165 | ||
Percent Insiders 48.44 | Percent Institutions 1.59 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Bon Natural Life Ltd
Company Overview
History and Background
Bon Natural Life Ltd was founded in 2015. They operate in the natural, health supplement and personal care product industries, focusing on research, development, manufacturing, and sales.
Core Business Areas
- Natural Bio-active Ingredients: Development and sales of natural extracts and ingredients used in food, beverage, and cosmetics.
- Finished Products: Manufacturing and distribution of finished health and personal care products under their own brands or for private label clients.
Leadership and Structure
The company is led by a management team with experience in the natural product and nutraceutical industries. Details of the specific leadership team and organizational structure are not widely available in public sources.
Top Products and Market Share
Key Offerings
- Plant Extracts: Various plant extracts used in health supplements and cosmetics. Market share data specific to Bon Natural Life is not readily available. Competitors include larger ingredient suppliers like Naturex (now Givaudan Active Beauty), and Indena.
- Finished Health Supplements: Finished health supplement products targeting various health needs. Specific market share data is unavailable. Competitors include large supplement brands like GNC (GNC), and The Vitamin Shoppe (VSI).
Market Dynamics
Industry Overview
The natural ingredients and health supplement industry is experiencing growth, driven by increasing consumer awareness of health and wellness and a preference for natural products. The competitive landscape is fragmented with numerous players of varying sizes.
Positioning
Bon Natural Life is positioned as a player focused on natural bio-active ingredients and finished products within the health and wellness market. Their competitive advantage is not very clear based on publicly available information.
Total Addressable Market (TAM)
The global nutraceuticals market size was valued at USD 467.67 billion in 2023 and is projected to grow from USD 507.77 billion in 2024 to USD 968.68 billion by 2032. Bon Natural Life Ltd is a small player with respect to this overall TAM.
Upturn SWOT Analysis
Strengths
- Focus on natural ingredients
- Product diversification
- Manufacturing capabilities
Weaknesses
- Limited brand recognition
- Small market share
- Financial performance concerns
- Relatively high debt
Opportunities
- Growing demand for natural products
- Expansion into new markets
- Strategic partnerships
- Increase manufacturing throughput
Threats
- Intense competition
- Regulatory changes
- Fluctuations in raw material prices
- Supply Chain issues
Competitors and Market Share
Key Competitors
- GNC
- VSI
- GIVAF.SW
Competitive Landscape
Bon Natural Life faces significant competition from larger, more established players with greater brand recognition and resources. Bon Natural Life's differentiation strategy needs to be stronger to compete effectively.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Not available without robust financial data.
Future Projections: Future growth projections are uncertain without detailed financial analysis.
Recent Initiatives: Not available from the public domain.
Summary
Bon Natural Life Ltd operates in a growing market with a focus on natural ingredients and finished products. However, it faces challenges due to strong competition, limited brand recognition, and financial performance concerns. The company needs to strengthen its brand, improve its financial performance, and differentiate itself from competitors to achieve sustainable growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Market Research Reports
Disclaimers:
The data and analysis provided are based on publicly available information and should not be considered financial advice. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Bon Natural Life Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-06-24 | Chairman & CEO Mr. Yongwei Hu | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 97 | Website https://www.bnlus.com |
Full time employees 97 | Website https://www.bnlus.com | ||
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. Bon Natural Life Limited was founded in 2006 and is based in Xi'an, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.